Novavax is on thin ice, and the latest update isn’t exactly encouraging
Today's biotech updates include Roche and Sanofi earnings, a look at Bluebird Bio, and the uncertain future of Novavax's Covid-19 vaccine.
Read The StoryCoronavirus
Coronavirus news: From the first days of the coronavirus outbreak, through the Covid-19 pandemic and now into the travails of long Covid, STAT has provided award-winning coverage.
It’s too early to say which Covid-19 variants may be future threats, if the virus will fall into a seasonal pattern, or if new comprehensive treatment approaches are near. What’s clear is that it’s been a confounding disease: People who tested negative for coronavirus can still get long Covid.
Supreme Court to weigh whether Covid misinformation is protected speech
Covid took a toll on heart health — and doctors are still grappling with how to help
What explains rare heart condition among young men after Covid vaccines? A new study offers clues
Encouraged by right-wing doctor groups, desperate patients turn to ivermectin for long Covid
All Coverage
advertisement
